Stay updated on Olaparib in gBRCA Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record presents details of the completed POLO study of maintenance olaparib versus placebo for people with germline BRCA-mutated metastatic pancreatic cancer, including eligibility, outcomes, locations, and study documents.
    Difference
    93%
    Check dated 2026-11-10T18:58:36.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T19:06:06.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology during the agency transition was added, and the site revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:27:14.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:53:30.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, with the study content replaced by an error screen and the original study details no longer visible. This blocks access to core trial information such as the study overview, eligibility criteria, outcomes, and locations.
    Difference
    17%
    Check dated 2026-09-22T22:27:46.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A new revision tag, v3.7.0, appears on the page, replacing the previous v3.6.6. This indicates a minor maintenance release rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-09-15T21:36:08.000Z thumbnail image

Stay in the know with updates to Olaparib in gBRCA Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.